Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1600 patients
Y. Kanpolat et al., Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1600 patients, NEUROSURGER, 48(3), 2001, pp. 524-532
OBJECTIVE: The objective of this study was to evaluate the effectiveness of
percutaneous, controlled radiofrequency trigeminal rhizotomy (RF-TR). The
outcome of 1600 patients with idiopathic trigeminal neuralgia after RF-TR w
as analyzed after a follow-up period of 1 to 25 years.
METHODS: A total of 1600 patients with idiopathic trigeminal neuralgia unde
rwent 2138 percutaneous radiofrequency rhizotomy procedures between 1974 an
d 1999. Sixty-seven patients had bilateral idiopathic trigeminal neuralgia,
and 36 of them were treated with bilateral RF-TR; 1216 patients (76%) were
successfully managed with a single procedure, and the remainder were treat
ed with multiple procedures. Benzodiazepines and narcotic analgesics were u
sed for anesthesia because patient cooperation during the procedures was es
sential so that the physician could create selective, controlled lesions.
RESULTS: The average follow-up time was 68.1 +/- 66.4 months (range, 12-300
mo). Acute pain relief was accomplished in 97.6% of patients. Complete pai
n relief was achieved at 5 years in 57.7% of the patients who underwent a s
ingle procedure. Pain relief was reported in 92% of patients with a single
procedure or with multiple procedures 5 years after the first rhizotomy was
performed. At 10-year follow-up, 52.3% of the patients who underwent a sin
gle procedure and 94.2% of the patients who underwent multiple procedures h
ad experienced pain relief; at 20-year follow-up, 41 and 100% of these pati
ents, respectively, had experienced pain relief. No mortalities occurred. A
fter the first procedure was performed, early pain recurrence (<6 mo) was o
bserved in 123 patients (7.7%) and late pain recurrence was observed in 278
patients (17.4%). Complications included diminished corneal reflex in 91 p
atients (5.7%), masseter weakness and paralysis in 66 (4.1%), dysesthesia i
n 16 (1%), anesthesia dolorosa in 12 (0.8%), keratitis in 10 (0.6%), and tr
ansient paralysis of Cranial Nerves III and VI in 12 (0.8%). Permanent Cran
ial Nerve VI palsy was observed in two patients, cerebrospinal fluid leakag
e in two, carotid-cavernous fistula in one, and aseptic meningitis in one.
CONCLUSION: Percutaneous, controlled RF-TR represents a minimally invasive,
low-risk technique with a high rate of efficacy. The procedure may safely
be repeated if pain recurs.